173 related articles for article (PubMed ID: 8887597)
1. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):994-1001. PubMed ID: 8887597
[TBL] [Abstract][Full Text] [Related]
2. Oxygen improves maximal exercise performance in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1616-22. PubMed ID: 7952624
[TBL] [Abstract][Full Text] [Related]
3. Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis.
McKone EF; Barry SC; Fitzgerald MX; Gallagher CG
J Appl Physiol (1985); 2005 Sep; 99(3):1012-8. PubMed ID: 15860682
[TBL] [Abstract][Full Text] [Related]
4. Dead space loading and exercise limitation in patients with interstitial lung disease.
Marciniuk DD; Watts RE; Gallagher CG
Chest; 1994 Jan; 105(1):183-9. PubMed ID: 8275730
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular response patterns during exercise in interstitial lung disease.
Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
[TBL] [Abstract][Full Text] [Related]
6. Low-dose nebulized morphine does not improve exercise in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1940-5. PubMed ID: 8520759
[TBL] [Abstract][Full Text] [Related]
7. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease.
O'Donnell DE; Chau LK; Webb KA
J Appl Physiol (1985); 1998 Jun; 84(6):2000-9. PubMed ID: 9609795
[TBL] [Abstract][Full Text] [Related]
8. Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease.
Dodd JD; Barry SC; Gallagher CG
Respir Physiol Neurobiol; 2006 Jun; 152(2):176-85. PubMed ID: 16169290
[TBL] [Abstract][Full Text] [Related]
9. Carotid chemoreceptors and respiratory adaptations to dead space loading during incremental exercise.
Syabbalo NC; Zintel T; Watts R; Gallagher CG
J Appl Physiol (1985); 1993 Sep; 75(3):1378-84. PubMed ID: 8226554
[TBL] [Abstract][Full Text] [Related]
10. Effects of 100 % oxygen during exercise in patients with interstitial lung disease.
Cournoyer J; Ramos CF; Sturgill B; Tang F; DeLuca N; Mirsaeidi M; Jackson RM
Respir Physiol Neurobiol; 2020 Mar; 274():103367. PubMed ID: 31911201
[TBL] [Abstract][Full Text] [Related]
11. Role of respiratory function in exercise limitation in chronic heart failure.
Chauhan A; Sridhar G; Clemens R; Krishnan B; Marciniuk DD; Gallagher CG
Chest; 2000 Jul; 118(1):53-60. PubMed ID: 10893359
[TBL] [Abstract][Full Text] [Related]
12. Lung volume reduction surgery improves maximal O2 consumption, maximal minute ventilation, O2 pulse, and dead space-to-tidal volume ratio during leg cycle ergometry.
Benditt JO; Lewis S; Wood DE; Klima L; Albert RK
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):561-6. PubMed ID: 9279240
[TBL] [Abstract][Full Text] [Related]
13. Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease.
Oelberg DA; Kacmarek RM; Pappagianopoulos PP; Ginns LC; Systrom DM
Am J Respir Crit Care Med; 1998 Dec; 158(6):1876-82. PubMed ID: 9847281
[TBL] [Abstract][Full Text] [Related]
14. Response to symptom-limited exercise in patients with the hepatopulmonary syndrome.
Epstein SK; Zilberberg MD; Jacoby C; Ciubotaru RL; Kaplan LM
Chest; 1998 Sep; 114(3):736-41. PubMed ID: 9743159
[TBL] [Abstract][Full Text] [Related]
15. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease.
Marciniuk DD; Sridhar G; Clemens RE; Zintel TA; Gallagher CG
J Appl Physiol (1985); 1994 Aug; 77(2):963-73. PubMed ID: 8002554
[TBL] [Abstract][Full Text] [Related]
16. Ventilatory mechanics and gas exchange during exercise before and after lung volume reduction surgery.
Tschernko EM; Gruber EM; Jaksch P; Jandrasits O; Jantsch U; Brack T; Lahrmann H; Klepetko W; Wanke T
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1424-31. PubMed ID: 9817689
[TBL] [Abstract][Full Text] [Related]
17. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired D
Smyth RM; James MD; Vincent SG; Milne KM; Marillier M; Domnik NJ; Parker CM; de-Torres JP; Moran-Mendoza O; Phillips DB; O'Donnell DE; Neder JA
Respir Care; 2023 Nov; 68(12):1662-1674. PubMed ID: 37643871
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and consequences of excess exercise ventilation in fibrosing interstitial lung disease.
Plachi F; Balzan FM; Gass R; Käfer KD; Santos AZ; Gazzana MB; Neder JA; Berton DC
Respir Physiol Neurobiol; 2024 Jul; 325():104255. PubMed ID: 38555042
[TBL] [Abstract][Full Text] [Related]
19. Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease.
Holland AE; Hill CJ; Glaspole I; Goh N; Dowman L; McDonald CF
Respir Med; 2013 Jul; 107(7):1066-72. PubMed ID: 23669412
[TBL] [Abstract][Full Text] [Related]
20. Respiratory adaptations to dead space loading during maximal incremental exercise.
McParland C; Mink J; Gallagher CG
J Appl Physiol (1985); 1991 Jan; 70(1):55-62. PubMed ID: 2010409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
